Company Filing History:
Years Active: 2006
Title: Ines Eberhardt: Innovating Drug Target Identification
Introduction: Ines Eberhardt, based in Zwalm, Belgium, is an accomplished inventor contributing to the field of medical research. With one notable patent to her name, Eberhardt is making strides in the identification of drug targets related to yeast and fungal diseases.
Latest Patents: Eberhardt's patent, titled "Bax-responsive genes for drug target identification in yeast and fungi," focuses on the use of nucleic acids and polypeptides involved in pathways that lead to programmed cell death in yeast and fungi. This innovative work aims to prepare medicaments for treating diseases associated with these organisms, addressing proliferative disorders and preventing unwanted cell death in certain diseases. The patent also outlines methods for identifying compounds that can selectively modulate the expression or functionality of the involved polypeptides, as well as detailing new nucleic acid sequences, probes, primers, and various pharmaceutical compositions.
Career Highlights: Ines Eberhardt works at Janssen Pharmaceutica NV, a prominent player in the pharmaceutical industry. Her work exemplifies the impact that dedicated inventors can have on developing effective treatments and advancing medical science.
Collaborations: Throughout her career, Eberhardt has collaborated with notable colleagues such as Roland Henri Contreras and Walter Herman Maria Luyten. These partnerships underline the importance of teamwork in driving innovation and achieving significant results in the field of health and medicine.
Conclusion: Ines Eberhardt's contributions to drug target identification showcase her innovative spirit and commitment to scientific advancement. With her patent focused on critical health issues related to yeast and fungi, Eberhardt continues to pave the way for new therapeutic solutions. Her collaborations and work at Janssen Pharmaceutica NV highlight her significant role in the ongoing quest to improve patient outcomes through research and invention.